Examining the Flexibility of RNAi-Based Therapy: Targeting C3, C5 & Complement Factor B

Time: 2:40 pm
day: Conference Day One

Details:

  • Sirnaomics’ approach of using oligonucleotides in hepatocytes for gene/protein targeting
  • Identify the benefits of a combination approach with STP247G’s ability to target complement Factor CFB/C5 simultaneously
  • Explore the scientific decisions behind which factor to target for certain diseases

Speakers: